The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease
Open accessAbstract
The blood–brain barrier (BBB) limits the entry of neurotoxic blood-derived products and cells into the brain that is required for normal neuronal functioning and information processing. Pericytes maintain the integrity of the BBB and degenerate in Alzheimer’s disease (AD). The BBB is damaged in AD, particularly in individuals carrying apolipoprotein E4 ( APOE4) gene, which is a major genetic risk factor for late-onset AD. The mechanisms underlying the BBB breakdown in AD remain, however, elusive. Here, we show accelerated pericyte degeneration in AD APOE4 carriers >AD APOE3 carriers >non-AD controls, which correlates with the magnitude of BBB breakdown to immunoglobulin G and fibrin. We also show accumulation of the proinflammatory cytokine cyclophilin A (CypA) and matrix metalloproteinase-9 (MMP-9) in pericytes and endothelial cells in AD ( APOE4 > APOE3), previously shown to lead to BBB breakdown in transgenic APOE4 mice. The levels of the apoE lipoprotein receptor, low-density lipoprotein receptor-related protein-1 (LRP1), were similarly reduced in AD APOE4 and APOE3 carriers. Our data suggest that APOE4 leads to accelerated pericyte loss and enhanced activation of LRP1-dependent CypA–MMP-9 BBB-degrading pathway in pericytes and endothelial cells, which can mediate a greater BBB damage in AD APOE4 compared with AD APOE3 carriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The loss of pericytes is probably caused by increased expression of friend leukemia virus integration 1 (Fli-1) after being activated.503”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [503]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Human APOE4 carriers compared with non-carriers develop accelerated BBB breakdown and pericyte degeneration (229, 230, 267, 516, 691, 702), early neurovascular dysfunction (494, 531, 584), impaired cerebrovascular reactivity (227, 568), and diminished regional BBB uptake of glucose (457, 486).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These blood-derived proteins are often found colocalized with A 𝛃 (267, 509, 527) and are more pronounced in APOE4 carriers compared with noncarriers (230, 267, 516, 691).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Post mortem studies show vascular capillary leakages of blood-derived proteins in the prefrontal and entorhinal cortex and hippocampus of AD patients including perivascular accumulation of fibrin(ogen), thrombin, albumin, immunoglobulin G (IgG), and iron-containing proteins such as hemosiderin (120, 125, 230, 267, 412, 509, 527, 691).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further evidence of BBB breakdown in AD is repeatedly observed in numerous post mortem human studies showing reduced capillary length and microvascular degeneration with diminished TJ protein expression, capillary basement membrane alterations, and brain endothelial degeneration (36, 40, 230, 516, 527, 656).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Brain pericytes and endothelial cells in AD APOE4 carriers exhibit increased activity of BBB-degrading CypA-MMP-9 pathway compared with noncarriers (230).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Activation of CypAMMP-9 pathway associated with BBB breakdown has also been shown in human APOE4 carriers compared with noncarriers, as indicated by CSF (229) and post mortem BBB tissue (230) analyses.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In AD patients, BBB damage is associated with loss of pericytes,503 while the decrease in pericytes is followed by an increase in activated microglia.504”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [503]
The cited source says what the claim attributes to it.
In the citing paper
“For example, APOE4 carriers at risk for sporadic AD compared with non-carriers develop BBB breakdown (229, 230, 267, 516, 691, 702) and early cerebrovascular dysfunction (227, 457, 486, 494, 531, 568, 584)”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
The cited source says what the claim attributes to it.
In the citing paper
“Activation of CypA-MMP-9 pathway associated with BBB breakdown has been also shown in human APOE4 carriers by cerebrospinal fluid (CSF) analysis (229) and post mortem brain tissue analysis (230, 267).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
The cited source says what the claim attributes to it.
In the citing paper
“Similarly, PDGFR 𝛃 immunostaining revealed significantly reduced pericyte coverage of brain capillaries as well as reduced pericyte numbers in AD cortex and hippocampus compared with control brains (527), which is accelerated by APOE4 gene (230).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
The cited source says what the claim attributes to it.
In the citing paper
“AD brain microvessels also exhibit reduced levels of LRP1, a major A 𝛃 clearance receptor at the BBB (137, 152, 230, 410, 535).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [230]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589
Self-citationRetractedThe Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Pericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Self-citationThe role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448
Self-citationShibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Self-citationApolipoprotein E controls cerebrovascular integrity via cyclophilin A
Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman, D. M., Betsholtz, C., Armulik, A., Sallstrom, J., et al. (2012) · Nature · doi:10.1038/nature11087 · Cited by 1,293 · cited 11×
“Microvascular capillary length was quantified as the length of lectin-positive endothelial profiles (<6 mm in diameter) determined using the ImageJ plug-in length analysis tool from 15 images per specimen derived from five randomly selected fields in the cortex (420mm 420 mm) per section from three non-adjacent ( 100…”
BackgroundMethodResultInfluentialSelf-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 657
Cocaine-induced release of CXCL10 from pericytes regulates monocyte transmigration into the CNS
Niu, F., Liao, K., Hu, G., Sil, S., Callen, S. E., Guo, M., Yang, L., & Buch, S. J. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201712011 · Cited by 56
Zou, C., Mifflin, L., Hu, Z., Zhang, T., Shan, B., Wang, H., Xing, X., Zhu, H., Adiconis, X., Levin, J. Z., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108447 · Cited by 61
Qiu, C., Yuan, Z., He, Z., Chen, H., Liao, Y., Li, S., Zhou, W., & Song, Z. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.606986 · Cited by 55
Neurodegeneration cell per cell
Balusu, S., Praschberger, R., Lauwers, E., Strooper, B. D., & Verstreken, P. (2023) · Neuron · doi:10.1016/j.neuron.2023.01.016 · Cited by 53
The role of neurovascular unit damage in the occurrence and development of Alzheimer’s disease
Liu, X., Hou, D., Lin, F., Luo, J., Xie, J., Wang, Y., & Tian, Y. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0056 · Cited by 55
Mukhara, D., Oh, U., & Neigh, G. N. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00017-5 · Cited by 60
Zhao, Q., Dai, W., Chen, H. Y., Jacobs, R. E., Zlokovic, B. V., Lund, B. T., Montagne, A., & Bonnin, A. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113310119 · Cited by 52
Quantitative Water Permeability Mapping of Blood-Brain-Barrier Dysfunction in Aging
Ford, J. N., Zhang, Q., Sweeney, E. M., Merkler, A. E., de Leon, M. J., Gupta, A. K., Nguyen, T. D., & Ivanidze, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.867452 · Cited by 53
Tian, J., Shi, R., Liu, T., She, R., Wu, Q., An, J., Hao, W., & Soomro, M. H. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00052 · Cited by 52
The Role of Basement Membranes in Cerebral Amyloid Angiopathy
Howe, M. D., McCullough, L. D., & Urayama, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.601320 · Cited by 50
He, Z., Wang, G., Wu, J., Tang, Z., & Luo, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111667 · Cited by 50
What Are the Roles of Pericytes in the Neurovascular Unit and Its Disorders?
Benarroch, E. E. (2023) · Neurology · doi:10.1212/wnl.0000000000207379 · Cited by 55
Lewandowski, S. A., Fredriksson, L., Lawrence, D. A., & Eriksson, U. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.016 · Cited by 54
Ikonomović, M. D., Mi, Z., & Abrahamson, E. E. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.11.003 · Cited by 53
Pericyte Plasticity in the Brain
Santos, G. S. P., Magno, L. A. V., Romano‐Silva, M. A., Mintz, A., & Birbrair, A. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0296-5 · Cited by 53
Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles
Islam, Y., Leach, A. G., Smith, J. A., Pluchino, S., Coxon, C. R., Sivakumaran, M., Downing, J. R., Fatokun, A. A., Teixidò, M., & Ehtezazi, T. (2021) · Advanced Science · doi:10.1002/advs.202002085 · Cited by 52
Yue, Q., Leng, X., Xie, N., Zhang, Z., Yang, D., & Hoi, M. P. M. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70079 · Cited by 48
Tenreiro, M. M. B., Ferreira, R., Bernardino, L. I., & Brito, M. A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.014 · Cited by 52
Location Matters: Navigating Regional Heterogeneity of the Neurovascular Unit
Bernier, L., Brunner, C., Cottarelli, A., & Balbi, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.696540 · Cited by 52
Microglia directly associate with pericytes in the central nervous system
Morris, G. P., Foster, C. G., Courtney, J., Collins, J. M., Cashion, J. M., Brown, L. S., Howells, D. W., DeLuca, G. C., Canty, A. J., King, A. E., et al. (2023) · Glia · doi:10.1002/glia.24371 · Cited by 52
Tipping points in neurodegeneration
Simons, M., Levin, J., & Dichgans, M. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.031 · Cited by 52
Engstrom, A. K., Snyder, J. M., Maeda, N., & Xia, Z. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0155-2 · Cited by 51
Physiological and Pathological Ageing of Astrocytes in the Human Brain
Verkerke, M., Hol, E. M., & Middeldorp, J. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03256-7 · Cited by 51
Pericytes Across the Lifetime in the Central Nervous System
Bennett, H. C., & Kim, Y. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.627291 · Cited by 49
Li, J., Long, Q., Ding, H., Wang, Y., Luo, D., Li, Z., & Zhang, W. (2024) · Advanced Science · doi:10.1002/advs.202308677 · Cited by 47
Schreiber, S., Wilisch-Neumann, A., Schreiber, F., Assmann, A., Scheumann, V., Perosa, V., Jandke, S., Mawrin, C., Carare, R. O., & Werring, D. J. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12576 · Cited by 50
Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer’s disease
D'Cunha, N. M., McKune, A. J., Panagiotakos, D. B., Georgousopoulou, E. N., Thomas, J., Mellor, D. D., & Naumovski, N. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1349032 · Cited by 47
Watson, A. N., Berthiaume, A., Faino, A., McDowell, K. P., Bhat, N. R., Hartmann, D. A., & Shih, A. Y. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19900543 · Cited by 44
Jia, Y., Wang, N., Zhang, Y., Xue, D., Lou, H., & Liu, X. (2020) · Aging and Disease · doi:10.14336/ad.2019.0519 · Cited by 50
Lobo, D. D., Nobre, R. J., Miranda, C. O., Pereira, D., Castelhano, J., Sereno, J., Koeppen, A. H., Castelo-Branco, M. S., & de Almeida, L. P. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00955-0 · Cited by 45
HIV Alters Gap Junction-Mediated Intercellular Communication in Human Brain Pericytes
Cho, H. J., Kuo, A. M.-S., Bertrand, L., & Toborek, M. J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00410 · Cited by 46
Pericytes: Problems and Promises for CNS Repair
Laredo, F., Plebanski, J., & Tedeschi, A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00546 · Cited by 44
“Analysis of these tissues highlights accelerated pericyte loss in AD tissues when compared to controls, which correlates with the degree of BBB damage and extravascular accumulation of the plasma proteins IgG and fibrin (Halliday et al., 2016).”
BackgroundDysfunction of the neurovascular unit in diabetes-related neurodegeneration
Yan, C., Zhou, Y., Chen, Q., Luo, Y., Zhang, J. H., Huang, H., & Shao, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110656 · Cited by 47
Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease
Custodia, A., Aramburu-Núñez, M., Rodríguez‐Arrizabalaga, M., Peleteiro, J. M. P., Vázquez‐Vázquez, L., Camino-Castiñeiras, J., Aldrey, J. M., Castillo, J., Ouro, A., Sobrino, T., et al. (2023) · Cells · doi:10.3390/cells12060962 · Cited by 47
Deák, F., Freeman, W. M., Ungvari, Z. I., Csiszár, A., & Sonntag, W. E. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv206 · Cited by 45
Focused ultrasound as a novel strategy for Alzheimer disease therapeutics
Meng, Y., Volpini, M., Black, S. E., Lozano, A. M., Hynynen, K., & Lipsman, N. (2017) · Annals of Neurology · doi:10.1002/ana.24933 · Cited by 45
The role of pericytes in brain disorders: from the periphery to the brain
Hirunpattarasilp, C., Attwell, D., & Freitas, F. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14725 · Cited by 44
Wu, Y., Yang, X., Li, X., Wang, H., & Wang, T. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04292-x · Cited by 43
Novel Targets for Alzheimer's Disease: A View Beyond Amyloid
Ray, W. J., & Buggia-Prévot, V. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-052919-120219 · Cited by 47
Dysfunction of the Blood-brain Barrier in Cerebral Microbleeds: from Bedside to Bench
Wang, H., Zhang, C., Qiu, Y., Chen, A., Li, Y., & Hu, B. (2021) · Aging and Disease · doi:10.14336/ad.2021.0514 · Cited by 47
Yeh, T.-C., Kuo, C.-T., & Chou, Y.-B. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.860759 · Cited by 43
Jana, A., Wang, X., Leasure, J. W., Magana, L., Wang, L., Kim, Y.-M., Dodiya, H., Toth, P. T., Sisodia, S. S., & Rehman, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-20889-y · Cited by 43
Ding, Q., Tanigawa, K., Kaneko, J., Totsuka, M., Katakura, Y., Imabayashi, E., Matsuda, H., & Hisatsune, T. (2018) · Aging and Disease · doi:10.14336/ad.2017.0809 · Cited by 43
Endothelial Progenitor Cells and Vascular Alterations in Alzheimer’s Disease
Custodia, A., Ouro, A., Romaus‐Sanjurjo, D., Peleteiro, J. M. P., de Vries, H. E., Castillo, J., & Sobrino, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.811210 · Cited by 45
Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders
Turri, M., Marchi, C., Adorni, M. P., Calabresi, L., & Zimetti, F. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159123 · Cited by 54
Hu, Y., Hu, X.-D., He, Z., Liu, Y., Gui, Y.-K., Zhu, S.-H., Da, X., Liu, Y., Liu, L., Shen, Q., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112290 · Cited by 48
Petralla, S., Panayotova, M., Franchina, E., Fricker, G., & Puris, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070948 · Cited by 46
Yue, J. K., Robinson, C. K., Burke, J. F., Winkler, E. A., Deng, H., Cnossen, M. C., Lingsma, H. F., Ferguson, A. R., McAllister, T. W., Rosand, J. M., et al. (2017) · Brain and Behavior · doi:10.1002/brb3.791 · Cited by 41
Self-citationWu, Q., Yuan, X., Bai, J., Han, R., Li, Z., Zhang, H., & Xiu, R. (2019) · Aging · doi:10.18632/aging.102171 · Cited by 44
Advanced Human BBB‐on‐a‐Chip: A New Platform for Alzheimer's Disease Studies
Yoon, J., Kim, J., Shah, Z., Awasthi, A., Mahajan, A., & Kim, Y. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002285 · Cited by 45
ApoE4-Mediated Blood Brain Barrier Damage in Alzheimer's Disease: Progress and Prospects
Zhou, X., Shi, Q., Zhang, X., Gu, L., Li, J., Ju, Y., Hu, M., Zhao, X., & Li, Q. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110670 · Cited by 40
Thomas, R., Morris, A. W. J., & Tai, L. M. (2017) · Heliyon · doi:10.1016/j.heliyon.2017.e00319 · Cited by 41
Gustafsson, S. S., Lindström, V., Ingelsson, M., Hammarlund‐Udenaes, M., & Syvänen, S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.002 · Cited by 39
Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier
Shackleton, B., Ringland, C., Abdullah, L. I., MULLAN, M. J., Crawford, F., & Bachmeier, C. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01672-z · Cited by 40
Kirabali, T., Rigotti, S., Siccoli, A., Liebsch, F., Shobo, A., Höck, C., Nitsch, R. M., Multhaup, G., & Kulic, L. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0846-8 · Cited by 43
Kirabali, T., Rust, R., Rigotti, S., Siccoli, A., Nitsch, R. M., & Kulic, L. (2020) · Brain Pathology · doi:10.1111/bpa.12895 · Cited by 43
Crossing borders in Alzheimer’s disease: A T cell’s perspective
van Olst, L., Coenen, L., Nieuwland, J. M., Rodriguez-Mogeda, C., de Wit, N. M., Kamermans, A., Middeldorp, J., & de Vries, H. E. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114398 · Cited by 45
Wasielewska, J. M., Chaves, J. C. S., Johnston, R. L., Milton, L. A., Hernández, D., Chen, L., Song, J. H., Lee, W., Leinenga, G., Nisbet, R. M., et al. (2022) · Theranostics · doi:10.7150/thno.72685 · Cited by 41
Afsar, A., Castro, M. D. C. C., Soladogun, A. S., & Li, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087258 · Cited by 45
Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease
Galván, V., & Hart, M. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.010 · Cited by 41
Denser brain capillary network with preserved pericytes in Alzheimer's disease
Fernández‐Klett, F., Brandt, L., Fernández‐Zapata, C., Abuelnor, B., Middeldorp, J., Sluijs, J. A., Curtis, M. A., Faull, R. L. M., Harris, L. W., Bahn, S., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12897 · Cited by 40
Kirchner, K., Garvert, L., Kühn, A. L., Bonk, S., Grabe, H. J., & der Auwera, S. V. (2023) · Cells · doi:10.3390/cells12212512 · Cited by 39
The vascular contribution of apolipoprotein E to Alzheimer’s disease
Chen, F., Zhao, J., Meng, F., He, F., Ni, J., & Fu, Y. (2024) · Brain · doi:10.1093/brain/awae156 · Cited by 39
Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease
Šimić, G., Španić, E., Horvat, L. L., & Hof, P. R. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.003 · Cited by 40
Ha, I. H., Lim, C., Kim, Y., Moon, Y., Han, S., & Moon, W. (2021) · Korean Journal of Radiology · doi:10.3348/kjr.2020.0816 · Cited by 38
Barkaway, A., Attwell, D., & Korte, N. (2022) · Neurophotonics · doi:10.1117/1.nph.9.3.031914 · Cited by 38
Neurodegenerative Microbially-Shaped Diseases: Oxidative Stress Meets Neuroinflammation
Silva, D. F., Empadinhas, N., Cardoso, S. M., & Esteves, A. R. (2022) · Antioxidants · doi:10.3390/antiox11112141 · Cited by 44
Astrocytes: The Stars in Neurodegeneration?
Dittlau, K. S., & Freude, K. (2024) · Biomolecules · doi:10.3390/biom14030289 · Cited by 39
Bourassa, P., Tremblay, C., Schneider, J. A., Bennett, D. A., & Calon, F. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12599 · Cited by 38
Early-life stress induces the development of Alzheimer's disease pathology via angiopathy
Tanaka, T., Hirai, S., Hosokawa, M., Saito, T., Sakuma, H., Saido, T. C., Hasegawa, M., & Okado, H. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113552 · Cited by 39
Solovyev, N. D., El‐Khatib, A. H., Costas‐Rodríguez, M., Schwab, K., Griffin, E., Raab, A., Platt, B., Theuring, F., Vogl, J., & Vanhaecke, F. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100292 · Cited by 39
Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders
Uprety, A. R., Kang, Y., & Kim, S. Y. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01332-8 · Cited by 39
Marottoli, F. M., Trevino, T. N., Geng, X. H., Arbieva, Z. H., Kanabar, P. N., Maienschein‐Cline, M., Lee, J. C., Lutz, S. E., & Tai, L. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.668296 · Cited by 38
Ronaldson, P. T., & Davis, T. P. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071501 · Cited by 38
The toxic metal hypothesis for neurological disorders
Pamphlett, R., & Bishop, D. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1173779 · Cited by 44
Nock, T. G., Chouinard‐Watkins, R., & Plourde, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.004 · Cited by 37
Moore, A. M., Mahoney, E. R., Dumitrescu, L. C., Jager, P. L. D., Koran, M. E. I., Petyuk, V., Robinson, R. A. S., Ruderfer, D. M., Cox, N. J., Schneider, J. A., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.021 · Cited by 38
Shahim, P., & Zetterberg, H. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.10.010 · Cited by 36
Lee, J., Lee, H., Lee, H. G., Shin, M., Shin, M.-G., Seo, J., Lee, E. J., Park, S. A., & Park, S. (2023) · Nature Communications · doi:10.1038/s41467-023-44319-3 · Cited by 37
Gama, C. S. D., & Morin‐Brureau, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.863836 · Cited by 37
Role for apolipoprotein E in neurodegeneration and mercury intoxication
Lopez, M. E. C. (2017) · Frontiers in Bioscience-Elite · doi:10.2741/e819 · Cited by 35
Brain pericyte activation occurs early in Huntington's disease
Padel, T., Roth, M., Gaceb, A., Li, J., Björkqvist, M., & Paul, G. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.03.015 · Cited by 35
Yanai, S., Toyohara, J., Ishiwata, K., Ito, H., & Endo, S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.006 · Cited by 35
You, T.-Y., Dong, Q., & Cui, M. (2022) · Aging and Disease · doi:10.14336/ad.2022.1204 · Cited by 33
Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases
Jiménez, A., Estudillo, E., Guzmán‐Ruiz, M. A., Herrera, N., Victoria-Acosta, G., Cortés-Malagón, E. M., & López-Ornelas, A. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030281 · Cited by 36
The vascular contribution to cognitive decline in ageing and dementia
Anderle, S., Dixon, M., Quintela‐López, T., Sideris-Lampretsas, G., & Attwell, D. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00950-1 · Cited by 40
Sharma, H. S., Muresanu, D. F., Nozari, A., Lafuente, J. V., Tian, Z. R., Ozkızılcık, A., Manzhulo, I., Mössler, H., & Sharma, A. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.03.009 · Cited by 33
Montagne, A., Huuskonen, M. T., Rajagopal, G., Sweeney, M. D., Nation, D. A., Sepehrband, F., D’Orazio, L. M., Harrington, M. G., Chui, H. C., Law, M., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.07.012 · Cited by 33
Damodarasamy, M., Vernon, R. B., Pathan, J. L., Keene, C. D., Day, A. J., Banks, W. A., & Reed, M. J. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00219-y · Cited by 33
The Blood-Brain Barrier in Alzheimer’s Disease
Storck, S. E., Hartz, A. M. S., & Pietrzik, C. U. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_418 · Cited by 31
Suppression of Fli-1 protects against pericyte loss and cognitive deficits in Alzheimer's disease
Li, P., Wu, Y., Hamlett, E. D., Goodwin, A. J., Halushka, P. V., Carroll, S. L., Liu, M., & Fan, H. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.023 · Cited by 33
Mahaman, Y. A. R., Huang, F., Salissou, M. T. M., Yacouba, M. B. M., Wang, J., Liu, R., Zhang, B., Li, H., Zhu, F., & Wang, X. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01356-6 · Cited by 34
Gettings, S. M., Timbury, W., Dmochowska, A., Sharma, R., McGonigle, R., MacKenzie, L. E., Miquelard‐Garnier, G., & Bourbia, N. (2024) · NanoImpact · doi:10.1016/j.impact.2024.100508 · Cited by 34
Dysregulation of sonic hedgehog pathway and pericytes in the brain after lentiviral infection
Bohannon, D. G., Ko, A., Filipowicz, A. R., Kuroda, M. J., & Kim, W. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1463-y · Cited by 31
Central Nervous System Pericytes Contribute to Health and Disease
Girolamo, F., Errede, M., Bizzoca, A., Virgintino, D., & Ribatti, D. (2022) · Cells · doi:10.3390/cells11101707 · Cited by 32
Role of membrane biophysics in Alzheimer's–related cell pathways
Zhu, D., Bungart, B. L., Yang, X., Zhumadilov, Z. S., Lee, J. C., & Askarova, S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00186 · Cited by 32
Neurovascular dysfunction in dementia – human cellular models and molecular mechanisms
Parkes, I., Chintawar, S., & Cader, M. Z. (2018) · Clinical Science · doi:10.1042/cs20160720 · Cited by 33
Kim, S. Y., & Cheon, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102446 · Cited by 33
Sighencea, M. G., Popescu, R. Ș., & Trifu, S. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212311 · Cited by 33
Capillary Stalling: A Mechanism of Decreased Cerebral Blood Flow in AD/ADRD
Crumpler, R. F., Roman, R. J., & Fan, F. (2021) · Journal of Experimental Neurology · doi:10.33696/neurol.2.048 · Cited by 31
Metadata
- Authors
- Halliday, M. R., Rege, S. V., Ma, Q., Zhao, Z., Miller, C. A., Winkler, E. A., & Zlokovic, B. V.
- Affiliations
- University of Southern California (US)
- University of California, San Francisco (US)
- Department of Physiology and Biophysics, Center for Neurodegeneration and Regeneration, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2015-03-11
- Volume
- 36
- Issue
- 1
- Pages
- 216-227
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- PMC
- PMC4758554
- OpenAlex
- W2055467683
- Cited by
- 649
- References
- 41
- Citations by year
- 2026: 54 · 2025: 62 · 2024: 72 · 2023: 63 · 2022: 69 · 2021: 85 · 2020: 71 · 2019: 49 · 2018: 41 · 2017: 35 · 2016: 29 · 2015: 18
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Scholars Repository - LLU (Loma Linda University) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG023084, R01AG039452, R37AG023084, P50-AG05142, P50AG005142, R37AG23084, RF1AG039452)
- National Institute of Neurological Disorders and Stroke (R37NS034467, R01NS034467, R37NS34467)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, APOE ε4, blood-brain barrier disruption, pericyte degeneration, cyclophilin A, MMP-9, LRP1, IgG, fibrin, inflammatory cytokines, endothelial cells, APOE ε4 carriers
- MeSH terms
- Aged, Aged, 80 and over, Alleles, Alzheimer Disease, Blood-Brain Barrier, Cell Count, Endothelium, Vascular, Female, Humans, Male, Cohort Studies, Protein Isoforms, Pericytes, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
